Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity and safety of an inactivated Hepatitis A vaccine in healthy children aged 24 months to 15 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Inactivated hepatitis A vaccine (Hepatitis A vaccine, inactivated)

Snippet

Sponsor: Boryung Biopharma Co., Ltd. | Conditions: Hepatitis A, Hep A | Phase 3 | Status: UNKNOWN